Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of postmenopausal women with estrogen-responsive breast cancer.
| Product Name |
Anastrozole |
| CAS Number |
120511-73-1 |
| Therapeutic Class |
Antineoplastic, Aromatase Inhibitor |
| Dosage Form |
Oral tablet |
| Availability |
Commercial |
| Regulatory Status |
EDMF |